These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

244 related items for PubMed ID: 19820017

  • 1. Effects of aromatase inhibition on bone mineral density and bone turnover in older men with low testosterone levels.
    Burnett-Bowie SA, McKay EA, Lee H, Leder BZ.
    J Clin Endocrinol Metab; 2009 Dec; 94(12):4785-92. PubMed ID: 19820017
    [Abstract] [Full Text] [Related]

  • 2. Effect of aromatase inhibition on bone metabolism in elderly hypogonadal men.
    Leder BZ, Finkelstein JS.
    Osteoporos Int; 2005 Dec; 16(12):1487-94. PubMed ID: 15856361
    [Abstract] [Full Text] [Related]

  • 3. Effects of aromatase inhibition vs. testosterone in older men with low testosterone: randomized-controlled trial.
    Dias JP, Melvin D, Simonsick EM, Carlson O, Shardell MD, Ferrucci L, Chia CW, Basaria S, Egan JM.
    Andrology; 2016 Jan; 4(1):33-40. PubMed ID: 26588809
    [Abstract] [Full Text] [Related]

  • 4. Effects of suppression of estrogen action by the p450 aromatase inhibitor letrozole on bone mineral density and bone turnover in pubertal boys.
    Wickman S, Kajantie E, Dunkel L.
    J Clin Endocrinol Metab; 2003 Aug; 88(8):3785-93. PubMed ID: 12915670
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effects of aromatase inhibition in elderly men with low or borderline-low serum testosterone levels.
    Leder BZ, Rohrer JL, Rubin SD, Gallo J, Longcope C.
    J Clin Endocrinol Metab; 2004 Mar; 89(3):1174-80. PubMed ID: 15001605
    [Abstract] [Full Text] [Related]

  • 7. Aromatase inhibition in hypogonadal older men.
    Cohen P.
    Clin Endocrinol (Oxf); 2009 Dec; 71(6):896. PubMed ID: 19250262
    [No Abstract] [Full Text] [Related]

  • 8. Growth hormone and sex steroid effects on bone metabolism and bone mineral density in healthy aged women and men.
    Christmas C, O'Connor KG, Harman SM, Tobin JD, Münzer T, Bellantoni MF, Clair CS, Pabst KM, Sorkin JD, Blackman MR.
    J Gerontol A Biol Sci Med Sci; 2002 Jan; 57(1):M12-8. PubMed ID: 11773207
    [Abstract] [Full Text] [Related]

  • 9. Effect of anastrozole on hormone levels in postmenopausal women with early breast cancer.
    Kyvernitakis I, Albert US, Kalder M, Winarno AS, Hars O, Hadji P.
    Climacteric; 2015 Feb; 18(1):63-8. PubMed ID: 24884402
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The effect of aromatase inhibition on sex steroids, gonadotropins, and markers of bone turnover in older men.
    Taxel P, Kennedy DG, Fall PM, Willard AK, Clive JM, Raisz LG.
    J Clin Endocrinol Metab; 2001 Jun; 86(6):2869-74. PubMed ID: 11397902
    [Abstract] [Full Text] [Related]

  • 12. Aromatase Inhibitors Plus Weight Loss Improves the Hormonal Profile of Obese Hypogonadal Men Without Causing Major Side Effects.
    Colleluori G, Chen R, Turin CG, Vigevano F, Qualls C, Johnson B, Mediwala S, Villareal DT, Armamento-Villareal R.
    Front Endocrinol (Lausanne); 2020 Jun; 11():277. PubMed ID: 32499757
    [Abstract] [Full Text] [Related]

  • 13. The effects of the aromatase inhibitor anastrozole on bone metabolism and cardiovascular risk indices in ovariectomized, androgen-treated female-to-male transsexuals.
    Bunck MC, Toorians AW, Lips P, Gooren LJ.
    Eur J Endocrinol; 2006 Apr; 154(4):569-75. PubMed ID: 16556720
    [Abstract] [Full Text] [Related]

  • 14. Aromatase Inhibition Reduces Insulin Sensitivity in Healthy Men.
    Gibb FW, Homer NZ, Faqehi AM, Upreti R, Livingstone DE, McInnes KJ, Andrew R, Walker BR.
    J Clin Endocrinol Metab; 2016 May; 101(5):2040-6. PubMed ID: 26967690
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Differential regulation of gonadotropin secretion by testosterone in the human male: absence of a negative feedback effect of testosterone on follicle-stimulating hormone secretion.
    Hayes FJ, DeCruz S, Seminara SB, Boepple PA, Crowley WF.
    J Clin Endocrinol Metab; 2001 Jan; 86(1):53-8. PubMed ID: 11231978
    [Abstract] [Full Text] [Related]

  • 17. Gonadal steroid-dependent effects on bone turnover and bone mineral density in men.
    Finkelstein JS, Lee H, Leder BZ, Burnett-Bowie SA, Goldstein DW, Hahn CW, Hirsch SC, Linker A, Perros N, Servais AB, Taylor AP, Webb ML, Youngner JM, Yu EW.
    J Clin Invest; 2016 Mar 01; 126(3):1114-25. PubMed ID: 26901812
    [Abstract] [Full Text] [Related]

  • 18. Prevention of aromatase inhibitor-induced bone loss using risedronate: the SABRE trial.
    Van Poznak C, Hannon RA, Mackey JR, Campone M, Apffelstaedt JP, Clack G, Barlow D, Makris A, Eastell R.
    J Clin Oncol; 2010 Feb 20; 28(6):967-75. PubMed ID: 20065185
    [Abstract] [Full Text] [Related]

  • 19. A randomized, placebo-controlled study of the effects of denosumab for the treatment of men with low bone mineral density.
    Orwoll E, Teglbjærg CS, Langdahl BL, Chapurlat R, Czerwinski E, Kendler DL, Reginster JY, Kivitz A, Lewiecki EM, Miller PD, Bolognese MA, McClung MR, Bone HG, Ljunggren Ö, Abrahamsen B, Gruntmanis U, Yang YC, Wagman RB, Siddhanti S, Grauer A, Hall JW, Boonen S.
    J Clin Endocrinol Metab; 2012 Sep 20; 97(9):3161-9. PubMed ID: 22723310
    [Abstract] [Full Text] [Related]

  • 20. The role of aromatization in testosterone supplementation: effects on cognition in older men.
    Cherrier MM, Matsumoto AM, Amory JK, Ahmed S, Bremner W, Peskind ER, Raskind MA, Johnson M, Craft S.
    Neurology; 2005 Jan 25; 64(2):290-6. PubMed ID: 15668427
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.